19 Patent Results (6 families)
Make Note

Liposome Based Diepitope Constructs

  • Published: Dec 1, 2010
  • Filed: May 25, 2009
  • Earliest Priority: May 25 2009
  • Family: 2
  • Cited Works: 74
  • Cited by: 9
  • Cites: 2
  • Additional Info: Cited Works Published
  • Applicant: Pasteur Institut
Patent Application
EP 2255831 A1
121-687-079-081-887

Liposome Based Diepitope Constructs

  • Published: Dec 2, 2010
  • Filed: May 21, 2010
  • Earliest Priority: May 25 2009
  • Family: 2
  • Cited Works: 72
  • Cited by: 2
  • Cites: 2
  • Sequences: 10
  • Additional Info: Cited Works Full text Published Sequence
  • Applicant: Pasteur Institut, Centre Nat Rech Scient, Inst Nat Sante Rech Med, Mulard Laurence, Phalipon Armelle, Schuber Francis, Said Hassane Fatouma, Frisch Benoit
Patent Application
WO 2010/136947 A1
170-007-982-121-211

Injectable Vaccines Against Multiple Meningococcal Serogroups

  • Published: May 29, 2018
  • Filed: Aug 18, 2016
  • Earliest Priority: Jan 30 2003
  • Family: 40
  • Cited Works: 70
  • Cited by: 0
  • Cites: 45
  • Sequences: 12
  • Additional Info: Cited Works Full text Sequence
  • Owner: Glaxosmithkline Biologicals Sa, Novartis Ag, Chiron S.r.l, Novartis Vaccines And Diagnostics S.r.l
  • Applicant: Glaxosmithkline Biologicals Sa
Granted Patent
US 9981031 B2
002-014-495-668-256

Vaccines Comprising Multimeric Hsp60 Peptide Carriers

  • Published: Apr 9, 2013
  • Filed: Apr 11, 2007
  • Earliest Priority: Apr 11 2006
  • Family: 8
  • Cited Works: 48
  • Cited by: 0
  • Cites: 46
  • Sequences: 7
  • Additional Info: Cited Works Full text Published Sequence
  • Owner: Yeda Research And Development Co. Ltd. At The Weizmann Institute Of Science
  • Applicant: Cohen Irun R, Amir-kroll Hila, Cohen Noam, Nussbaum Gabriel, Yeda Res & Dev
Granted Patent
US 8414899 B2
061-104-060-069-317

Injectable Vaccines Against Multiple Meningococcal Serogroups

  • Published: Apr 30, 2019
  • Filed: Jan 30, 2004
  • Earliest Priority: Jan 30 2003
  • Family: 40
  • Cited Works: 55
  • Cited by: 0
  • Cites: 41
  • Sequences: 12
  • Additional Info: Cited Works Full text Sequence
  • Owner: Glaxosmithkline Biologicals Sa, Novartis Ag, Chiron S.r.l, Novartis Vaccines And Diagnostics S.r.l
  • Applicant: Costantino Paolo, Glaxosmithkline Biologicals Sa
Granted Patent
US 10272147 B2
034-756-530-780-66X

Capsular Polysaccharide Solubilisation

  • Published: Apr 10, 2013
  • Filed: Jun 20, 2002
  • Earliest Priority: Jun 20 2001
  • Family: 128
  • Cited Works: 7
  • Cited by: 0
  • Cites: 5
  • Additional Info: Cited Works Full text
  • Applicant: Novartis Ag
Granted Patent
EP 1401489 B2
172-133-625-157-304

Capsular Polysaccharide Solubilisation And Combination Vaccines

  • Published: Jun 17, 2014
  • Filed: Jun 20, 2002
  • Earliest Priority: Jun 20 2001
  • Family: 128
  • Cited Works: 78
  • Cited by: 7
  • Cites: 89
  • Additional Info: Cited Works Full text Published
  • Owner: Glaxosmithkline Biologicals Sa, Novartis Pharma Ag, Novartis Vaccines And Diagnostics S.r.l, Chiron S.r.l, Novartis Ag
  • Applicant: Costantino Paolo, Novartis Ag
Granted Patent
US 8753651 B2
036-336-118-057-658

Capsular Polysaccharide Solubilisation And Combination Vaccines

  • Published: Oct 7, 2014
  • Filed: Jan 14, 2009
  • Earliest Priority: Jun 20 2001
  • Family: 128
  • Cited Works: 81
  • Cited by: 0
  • Cites: 90
  • Additional Info: Cited Works Full text Published
  • Owner: Glaxosmithkline Biologicals Sa, Novartis Pharma Ag, Novartis Vaccines And Diagnostics S.r.l, Chiron S.r.l, Novartis Ag
  • Applicant: Costantino Paolo, Novartis Ag
Granted Patent
US 8852606 B2
024-436-764-730-280

Capsular Polysaccharides Solubilisation And Combination Vaccines

  • Published: Nov 18, 2014
  • Filed: Jan 9, 2009
  • Earliest Priority: Jun 20 2001
  • Family: 128
  • Cited Works: 50
  • Cited by: 4
  • Cites: 68
  • Additional Info: Cited Works Full text Published
  • Owner: Glaxosmithkline Biologicals Sa, Novartis Pharma Ag, Novartis Vaccines And Diagnostics Srl, Chiron Srl, Novartis Ag
  • Applicant: Costantino Paolo, Novartis Ag
Granted Patent
US 8889152 B2
018-085-979-976-49X

Capsular Polysaccharide Solubilisation And Combination Vaccines

  • Published: Jun 7, 2016
  • Filed: Jan 20, 2009
  • Earliest Priority: Jun 20 2001
  • Family: 128
  • Cited Works: 90
  • Cited by: 0
  • Cites: 90
  • Additional Info: Cited Works Full text Published
  • Owner: Glaxosmithkline Biologicals Sa, Novartis Pharma Ag, Novartis Vaccines And Diagnostics S.r.l, Chiron S.r.l, Novartis Ag
  • Applicant: Costantino Paolo, Novartis Ag
Granted Patent
US 9358278 B2
194-427-571-098-186
{{::'analysis.preview.CITED_WORKS_ANALYSIS.title' | message}} {{::'analysis.preview.view.full' | message}}

Add New Note

Sorry, you can't add a note to multiple items. You can add a note to your search as a saved query. Did you want to save this search and add a note to it?

Cancel Save
Search ORCID

Sign in to the Lens

Forgot Password? Register New Account
Feedback